Clinical trial
Investigational Drug Versus an Approved Drug in Patients With Rheumatoid…
NCT00092742 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00092742 |
|---|---|
| Title | Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072) |
| Official title | A Randomized, Double-Blind, Multicenter Study to Evaluate the Tolerability and Effectiveness of Etoricoxib 90 mg q.d. vs. Diclofenac Sodium 75 mg b.i.d. in Patients With Rheumatoid Arthritis |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | MK0663, etoricoxib, Comparator: Diclofenac sodium |
| Enrollment | 4,086 |
| Start date | Feb 1, 2003 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Sep 28, 2004 |
| Last update posted | Feb 16, 2022 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: